IONIS PHARMACEUTICALS INC (IONS) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for IONIS PHARMACEUTICALS INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, IONIS PHARMACEUTICALS INC's filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-10.02%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does IONIS PHARMACEUTICALS INC actually do?
Answer:
Ionis Pharmaceuticals is a fully integrated, commercial-stage biotechnology company pioneering RNA-targeted medicines to treat serious diseases. The company has seven marketed medicines: TRYNGOLZA, DAWNZERA, WAINUA, SPINRAZA, QALSODY, TEGSEDI, and WAYLIVRA. Ionis leverages its deep understanding of disease biology and an industry-leading drug discovery technology to develop innovative therapies across neurology, cardiometabolic diseases, and other areas of high patient need. The company reported revenues of $944 million in 2025 and ended the year with $2.7 billion in cash, cash equivalents, and short-term investments, positioning it for continued investment in its pipeline and commercial launches.
Question:
What are IONIS PHARMACEUTICALS INC's revenue drivers?
Answer:
Revenue is driven by sales of its marketed medicines, including TRYNGOLZA, DAWNZERA, WAINUA, SPINRAZA, QALSODY, TEGSEDI, and WAYLIVRA, as well as royalty revenue from partnered products. The company also generates revenue from collaboration and licensing agreements.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required